FOOTE SUSAN BARTLETT 4

Accession 0001127602-17-032090

CIK 0000313143other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:29 PM ET

Size

49.8 KB

Accession

0001127602-17-032090

Insider Transaction Report

Form 4

Period: 2017-11-10

HAEMONETICS CORPHAE

FOOTE SUSAN BARTLETT

Director

Transactions

Exercise/Conversion
Common Stock
2017-11-10$45.45/sh+6,573$298,743→ 27,313 total
Sale
Common Stock
2017-11-10$54.12/sh−600$32,472→ 24,113 total
Sale
Common Stock
2017-11-10$54.13/sh−600$32,478→ 23,513 total
Sale
Common Stock
2017-11-10$54.06/sh−290$15,677→ 27,023 total
Sale
Common Stock
2017-11-10$54.07/sh−200$10,814→ 26,823 total
Sale
Common Stock
2017-11-10$54.09/sh−400$21,636→ 26,423 total
Sale
Common Stock
2017-11-10$54.10/sh−510$27,591→ 25,913 total
Sale
Common Stock
2017-11-10$54.11/sh−1,200$64,932→ 24,713 total
Sale
Common Stock
2017-11-10$54.14/sh−200$10,828→ 23,313 total
Sale
Common Stock
2017-11-10$54.15/sh−573$31,028→ 22,740 total
Sale
Common Stock
2017-11-10$54.16/sh−100$5,416→ 22,640 total
Sale
Common Stock
2017-11-10$54.17/sh−1,900$102,923→ 20,740 total
Exercise/Conversion
Common Stock
2017-11-10$35.50/sh+10,353$367,557→ 31,093 total
Sale
Common Stock
2017-11-10$54.18/sh−1,061$57,485→ 28,893 total
Sale
Common Stock
2017-11-10$54.20/sh−100$5,420→ 28,193 total
Sale
Common Stock
2017-11-10$54.16/sh−100$5,416→ 30,993 total
Sale
Common Stock
2017-11-10$54.17/sh−1,039$56,283→ 29,954 total
Sale
Common Stock
2017-11-10$54.19/sh−600$32,514→ 28,293 total
Sale
Common Stock
2017-11-10$54.21/sh−200$10,842→ 27,993 total
Sale
Common Stock
2017-11-10$54.22/sh−2,500$135,550→ 25,493 total
Sale
Common Stock
2017-11-10$54.23/sh−500$27,115→ 24,993 total
Sale
Common Stock
2017-11-10$54.24/sh−400$21,696→ 24,593 total
Sale
Common Stock
2017-11-10$54.25/sh−2,953$160,200→ 21,640 total
Sale
Common Stock
2017-11-10$54.26/sh−100$5,426→ 21,540 total
Sale
Common Stock
2017-11-10$54.37/sh−200$10,874→ 21,340 total
Sale
Common Stock
2017-11-10$54.39/sh−100$5,439→ 21,240 total
Sale
Common Stock
2017-11-10$54.40/sh−100$5,440→ 21,140 total
Sale
Common Stock
2017-11-10$54.45/sh−100$5,445→ 21,040 total
Sale
Common Stock
2017-11-10$54.46/sh−200$10,892→ 20,840 total
Sale
Common Stock
2017-11-10$54.47/sh−100$5,447→ 20,740 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-11-10−6,573→ 0 total
Exercise: $45.45From: 2014-07-24Exp: 2023-07-24→ Common Stock (6,573 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2017-11-10−10,353→ 0 total
Exercise: $35.50From: 2014-07-22Exp: 2021-07-23→ Common Stock (10,353 underlying)

Footnotes (1)

[F1]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

HAEMONETICS CORP

CIK 0000313143

→

Entity typeother

Related Parties

filerCIK 0001244063

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 5:29 PM ET
Size: 49.8 KB

View on SEC.gov